A 52-Year-Old Woman With HER2-Positive Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
A 52-Year-Old Woman With HER2-Positive Breast Cancer | Targeted …
May 22, 2019
targetedonc.com
The Targeted Pulse: IL-21 Promises to Revolutionize Treatment for Glioblastoma, Pembrolizumab Trials Halted in Lung and Skin Cancer, and More | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Targeted Pulse: IL-21 Promises to Revolutionize Treatment for Gli…
Sep 8, 2024
targetedonc.com
Case 3: Essential Thrombocythemia (ET) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case 3: Essential Thrombocythemia (ET) | Targeted Oncology - Immun…
May 27, 2021
targetedonc.com
Understanding Treatment Options in Nasopharyngeal Carcinoma | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1:50
Understanding Treatment Options in Nasopharyngeal Carcinoma | Targ…
7 months ago
targetedonc.com
Molecular Monitoring Advances in PV Disease Assessment and Management | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Molecular Monitoring Advances in PV Disease Assessment and Mana…
7 months ago
targetedonc.com
Initial Treatment Options for mCRPC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Initial Treatment Options for mCRPC | Targeted Oncology - Immunother…
Nov 10, 2021
targetedonc.com
Evolving First-Line Treatment Strategies for uHCC. | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Evolving First-Line Treatment Strategies for uHCC. | Targeted O…
10 months ago
targetedonc.com
Addressing Unmet Needs in Renal Cell Carcinoma | Targeted Oncolo…
Apr 5, 2022
targetedonc.com
Multiple Myeloma Treatment: New Therapies vs Stem Cell Transplan…
Apr 3, 2024
targetedonc.com
Introduction & Case 1 Presentation: mHSPC | Targeted Oncology - Im…
10 months ago
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Desm…
Nov 28, 2023
targetedonc.com
Belumosudil Shows Sustained Efficacy and Safety for Chronic G…
Mar 11, 2024
targetedonc.com
Statistics on the Incidence of Chronic GVHD | Targeted Oncolog…
Jul 12, 2023
targetedonc.com
Options for MRD Testing Affect Patient Treatment Plan in Lung Ca…
9 months ago
targetedonc.com
ASH 2024 Preview for Community Oncologists: The Show and After …
11 months ago
targetedonc.com
The Differences Between mCRPC and nmCRPC | Targeted Oncolog…
Jul 17, 2019
targetedonc.com
A Case of Uncontrolled Polycythemia Vera | Targeted Onc…
May 12, 2022
targetedonc.com
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in …
Aug 2, 2024
targetedonc.com
Steroid-Refractory Acute Graft-Versus-Host Disease Defined | Tar…
Mar 22, 2021
targetedonc.com
Case 3: Disease Progression and Transformation in ET | Targeted O…
May 27, 2021
targetedonc.com
Case Presentation: 63-Year-Old Man With Advanced HCC | Targeted On…
Sep 9, 2019
targetedonc.com
Case 1: A Patient With Acute Graft-Vs-Host Disease | Targeted Oncol…
Jun 30, 2020
targetedonc.com
Nirogacestat Shows Improved PFS and Quick Response in Desmoid T…
9 months ago
targetedonc.com
When to Choose Chemotherapy vs CDK4/6 Inhibitors | Targeted Onco…
Apr 29, 2019
targetedonc.com
Overview: A 65-Year-Old Man with Metastatic Colorectal Cancer | Tar…
Sep 23, 2021
targetedonc.com
Case 3: A Patient With Metastatic HCC | Targeted Oncology - Immun…
Jan 3, 2022
targetedonc.com
Understanding GOG-0218 & ICON7 Trials | Targeted Oncology - Immu…
Apr 15, 2020
targetedonc.com
Treating Squamous vs Nonsquamous Disease | Targeted …
Nov 15, 2013
targetedonc.com
Overview: A 70-Year-Old Woman With Advanced Endometrial Canc…
Mar 1, 2022
targetedonc.com
See more videos
Static thumbnail place holder